Sponsor pipeline

ITM Solucin GmbH clinical trial pipeline

Get alerts when ITM Solucin GmbH's trials change

3 active trials 1 recruiting 2 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 1
1
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT03049189 Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients Neuroendocrine Tumors Active, Not Recruiting 2026-08-07
NCT04919226 Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive… Neuroendocrine Tumors Active, Not Recruiting 2025-09-10
Phase 1
NCT06441331 Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177… Somatostatin Receptor Positive Recruiting 2026-09-25

Disease areas by active trials

Sarcoma (1)

Get alerts when ITM Solucin GmbH's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free